Mishra, PPalaian, S2009-05-282009-05-282004-10-03Mishra P, Palaian S. Withdrawal of rofecoxib - a wake up call for drug safety. Kathmandu University Medical Journal. 2004 Oct-Dec; 2(4): 360http://imsear.searo.who.int/handle/123456789/46436Kathmandu University Medical Journal.engCyclooxygenase 2 Inhibitors --adverse effectsDrug ApprovalHumansLactones --adverse effectsNepalSafetySulfones --adverse effectsUnited StatesUnited States Food and Drug AdministrationWithdrawal of rofecoxib - a wake up call for drug safety.Journal Article